Behçet Clinical Trials

1 recruitingLast updated: May 5, 2026

There are 9 actively recruiting behçet clinical trials across 26 countries. Studies span Phase 3, Not Applicable, Phase 1. Top locations include Valencia, Valencia, Spain, Paris, France, Istanbul, Turkey (Türkiye). Updated daily from ClinicalTrials.gov.


Behçet Trials at a Glance

9 actively recruiting trials for behçet are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Valencia, Paris, and Istanbul. Lead sponsors running behçet studies include Amgen, Chugai Pharmaceutical, and Ataturk University.

Browse behçet trials by phase

Treatments under study

About Behçet Clinical Trials

Looking for clinical trials for Behçet? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Behçet trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Behçet clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS)Immune-mediated Necrotizing Myopathy (IMNM)Immune Thrombocytopenia (ITP)+3 more
Chugai Pharmaceutical144 enrolled69 locationsNCT06371417
Recruiting

Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls

Healthy (Controls)Takayasu ArteritisBehçet's Disease
ÖZLEM NUR TOK YAMAN30 enrolled1 locationNCT07276087
Recruiting
Phase 3

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease

Behçet Disease
Amgen60 enrolled27 locationsNCT04528082
Recruiting
Phase 3

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

Juvenile Psoriatic ArthritisBehçet's Disease
Amgen48 enrolled7 locationsNCT05767047
Recruiting

Ustekinumab in BEhçet's Syndrome STudy

Behçet's Syndrome (BS)
Groupe français d'étude des Maladies Inflammatoires de loeil208 enrolled11 locationsNCT07244614
Recruiting
Phase 3

A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

Behçet's Disease
Ganzhou Hemay Pharmaceutical Co., Ltd162 enrolled22 locationsNCT06145893
Recruiting

Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease

Behçet
Sohag University100 enrolled1 locationNCT06721234
Recruiting

Thrombophilia and Thrombosis in Behçet's Disease

Behçet Disease
Ataturk University200 enrolled1 locationNCT06451575
Recruiting
Not Applicable

Deployment o the Multidisciplinary Prospective Cohort Imminent

Severe AsthmaMultiple SclerosisAtopic Dermatitis+6 more
University Hospital, Lille2,200 enrolled1 locationNCT04334031